Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs PNC Financial Services Group Inc. (The) Common Stock (PNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while PNC Financial Services Group Inc. (The) Common Stock trades at $216.16 (market cap $87.56B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 9.9× Kymera Therapeutics Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays a 3.64% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KYMR | PNC | |
|---|---|---|
Market Cap | $8.87B | $87.56B |
Volume | 779,107 | 2,431,698 |
Sector | Health | Financials |
52-Week High | $127.31 | $256.97 |
52-Week Low | $55.80 | $178.37 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $8.26B | $144.55B |
Dividend Yield | — | 3.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PNC trades at $219.48, down 0.8% on the day, with a bearish technical signal but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue grew to $23.08B in 2025, with net income of $6.94B and a robust net income margin of 31.06%. Analyst consensus is a Buy with a $276.13 price target, indicating significant upside potential from current levels.
The outlook for PNC is positive given its earnings momentum and attractive valuation (P/E of 12.09), though risks include regulatory scrutiny and net cash outflows from investing activities. The stock offers a dividend yield supported by recent increases, positioning it as a value opportunity in the financial sector amid current bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About PNC Financial Services Group Inc. (The) Common Stock
PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →
